Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death

NCT02490020 is registered in ClinicalTrials.gov with Qipeng Sun as lead sponsor.

NCT NCT02490020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02490020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death
Lead sponsor
Qipeng Sun
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2016
Completion date
December 31, 2018
Enrollment
260 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

disorder related to renal transplantation, renal transplant rejection